Type 2 diabetes and anti-diabetic medications modify the risk of liver-related outcomes in subjects with non-alcoholic fatty liver disease and advanced fibrosis. Results of a multicenter international cohort study.
Refereed conference paper presented and published in conference proceedings


Full Text

Times Cited
Web of Science0WOS source URL (as at 13/10/2018) Click here for the latest count

Other information
All Author(s) ListBertot LC, Gomez EV, Wong VW, Fernandez MC, Aller R, Eslam M, George J, Romero-Gomez M, Adams LA
Name of Conference68th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting
Start Date of Conference20/10/2017
End Date of Conference24/10/2017
Place of ConferenceWashington, DC
Country/Region of ConferenceUnited States of America
Proceedings TitleHepatology
Year2017
Month10
Volume Number66
Issue NumberSuppl. 1
PublisherWiley
Pages1119A - 1119A
ISSN0270-9139
eISSN1527-3350
LanguagesEnglish-United States

Last updated on 2018-14-10 at 05:39